NeoGenomics, Inc. Business Acquisition, Pro Forma Earnings Per Share, Diluted
NeoGenomics, Inc. (NEO) reported Business Acquisition, Pro Forma Earnings Per Share, Diluted of $0.00 per share for the 3-month period ending 2014-09-30, per its 10-Q filed 2015-11-06.
Discontinued › Income Statement › Earnings Per Share
us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted · last filed 2015-11-06
- NeoGenomics, Inc. business acquisition, pro forma earnings per share, diluted for the quarter ending 2014-09-30 was $0.00.
| Period end | Business Acquisition, Pro Forma Earnings Per Share, Diluted 3 month | Business Acquisition, Pro Forma Earnings Per Share, Diluted 9 month |
|---|---|---|
| 2014-09-30 | $0.00 10-Q · filed 2015-11-06 | -$10.00 10-Q · filed 2015-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |